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An increasing number of reports suggest that Propionibacterium acnes can cause serious invasive infections. Currently only limited data exist regarding the spectrum of invasive P. acnes infections. 

Methods
Non-selective cohort study at a tertiary hospital in the UK over a nine-year-period (2003-2012) investigating clinical manifestations, risk factors, management and outcome of invasive P. acnes infections. 

Results
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INTRODUCTION
Propionibacteria are facultative anaerobic Gram-positive bacilli, which form part of the normal bacterial flora of the skin, sebaceous glands and hair follicles  ADDIN EN.CITE [1-3]. Propionibacterium acnes is thought to play a key role in the pathogenesis of common acne, and recent evidence suggest that this involves bacterial biofilm formation  ADDIN EN.CITE [1, 4, 5].

Due to the organism’s ubiquity, P. acnes isolates cultured from clinical specimens are often interpreted as contaminants. However, over the last decade increasing data have emerged showing that P. acnes can cause serious invasive infections. Recent data suggest that P. acnes can cause a diverse spectrum of infections, including central nervous system (CNS) infections, otitis media, sinusitis, lymphadenitis, endocarditis, septic arthritis, osteomyelitis and spondylodiscitis  ADDIN EN.CITE [6-13].

Most previous studies have focused on P. acnes infections in specific selected patient groups, such as neurosurgical patients, or patients who had undergone spinal surgery or joint replacements  ADDIN EN.CITE [11, 14-17]. Few studies have attempted to capture the full spectrum of P. acnes-related infections in a non-selective patient cohort  ADDIN EN.CITE [8, 9]. In addition, in most previous studies P. acnes infections were not the primary focus, and the vast majority of previous reports included fewer than twenty cases with invasive P. acnes infection  ADDIN EN.CITE [11, 14, 18-22].






In the absence of a universally accepted case definition for invasive P. acnes infection, we defined a case as follows: isolation of P. acnes in pure culture from 1) a specimen obtained during an open surgical procedure in conjunction with clinical evidence of infection at the corresponding site, or 2) a specimen from a normally sterile body site in conjunction with clinical evidence of infection at the corresponding site, or 3) cerebrospinal fluid (CSF) in conjunction with evidence of meningitis as indicated by an increased CSF white blood cell count (WBC; >20/μL in infants younger than 4 weeks, or >5/μL in older children and adults) [23], elevated protein and/or decreased glucose concentration (<60% of plasma glucose), or 4) at least two separately obtained blood cultures.

Patients and data collection
Potential cases were identified using the laboratory database of the Microbiology Department of the University Hospital Southampton NHS Foundation Trust, a tertiary healthcare institution providing services for approximately 3.5 million people in the South of England. The period studied was January 2003 to January 2012. 

An initial search identified all cultures that had isolated P. acnes. Due to the high potential for contamination (isolation of P. acnes as a commensal) skin swabs, oral samples, samples from the upper respiratory tract (throat swabs and nasopharyngeal aspirates) and vaginal swabs were excluded. This strategy produced a total of 176 potential cases.

To assess whether cases fulfilled the inclusion criteria and to collect additional data, the medical records of potential cases were reviewed by one of the investigators (MT). In cases where the causal implication of P. acnes was uncertain, a consensus between two investigators was sought (MT and CJ). 

The following data were extracted in cases that fulfilled the inclusion criteria: age at presentation, co-morbidities predisposing to infections (comprising immunodeficiency, diabetes, renal failure, immunosuppressive therapy, and malignancy), presenting symptoms and signs, laboratory results at presentation, risk factors for infection (including previous surgery or trauma, and presence of foreign material), antibiotic treatment, surgical management, and overall outcome. 

The normal ranges for inflammatory parameters were defined as: WBC: 4.0-11.0 x 109/L; neutrophils: 2.0-7.5 x109/L; C-reactive protein (CRP): 0-7.5 mg/L, erythrocyte sedimentation rate (ESR): 1-19 mm/hr.

Microbiological methods
Wound cultures and pus specimens were incubated on Fastidious Anaerobic Agar (Oxoid Limited; Basingstoke, UK) under anaerobic conditions for 5 days. CSF specimens from cerebral shunts were incubated for 14 days. Bacterial colonies were tested with the RapID™ ANA II Identification System (Remel/Thermo Fisher Scientific; Lenexa, KS, US); based on the biochemical reaction profile isolates were identified by use of the Remel ERIC® software. Susceptibility testing was carried out in accordance with the disc diffusion susceptibility testing guidelines issued by the British Society for Antimicrobial Chemotherapy (BSAC) [24]. Gradient minimum inhibitory concentration (MIC) testing was also performed to assess further treatment options for antibiotics that have no interpretive guidance as per BSAC guidelines.

Statistical analysis
All data were extracted into a standardised data collection sheet, and transferred into an Excel spreadsheet. STATA (StataCorp; College Station, TX, US) and Prism (GraphPad; La Jolla, CA, US) were used for data analyses and construction of the figures. Mann Whitney U and Fisher’s exact tests were used for the analysis of continuous and categorical data, respectively. P-values < 0.05 were considered to be statistically significant.

Ethical approval




From the 176 potential cases identified in the database search, the following did not meet the inclusion criteria and were therefore excluded: a) cases where P. acnes was grown from a CSF sample, but the CSF analysis was not suggestive of meningitis (n=36), b) cases where P. acnes was cultured together with another bacterial species in the same sample (n=24), c) cases where P. acnes was only grown in a single blood culture (n=15), d) cases without clinical evidence of infection at the site the sample originated from (n=12), e) cases where an alternative diagnosis was established (n=11). In addition, in 29 cases the records contained insufficient data regarding the time when P. acnes was cultured to determine whether the patient was symptomatic. Therefore a total of 49 cases were included in the final analysis. Of these, 28 were neurosurgical and 15 were orthopaedic infections. The remaining 6 cases had infections involving another normally sterile site.

Neurosurgical infections
The demographic characteristics of the 28 cases with neurosurgical infection are shown in Table 1. Ventriculo-peritoneal (VP) shunt infections (n=6), intracranial and subgaleal abscesses (n=5), and infections of intracranial cysts (n=3) were the most common types of infections in this group. Co-morbidities in this group included malignancy in 8 (28.6%), diabetes mellitus type II in 1 (3.6%) and renal failure in 1 (3.6%) case.

Predisposing factors for infection comprised prior neurosurgery in 96.4% of cases (27/28); the remaining patient had sustained a major head injury. Foreign material was in situ at the site of infection in 59.3% (16/27) of patients. VP shunts, extra-ventricular drains, Ommaya reservoirs or a combination thereof were the most common types of foreign material, present in 81.3% of those cases (13/16). The median time interval between surgery or trauma and presentation with P. acnes infection was 7.5 weeks (range 3.0-244.0 weeks). In patients with VP shunt infections the median incubation time to culture positivity was 7 days (range: 3-7 days).

The presenting symptoms and signs in this group are shown in Table 1. Both pyrexia and pain were uncommon presenting features, occurring only in 11.5% and 6.3% of cases, respectively. The most common findings at the surgical site were swelling (66.7%) and tenderness (50.0%). The most common neurological symptoms were focal neurological abnormalities (47.7%) and headache (33.3%).

The laboratory findings at presentation in this group are shown in Table 2. WBC and neutrophil counts were normal in 81.5% (22/27) and 65.4% (17/26) of cases, respectively. Among patients who had CRP analysed on admission, 52.4% (11/21) had results above the normal range. 

A combination of surgery and antibiotic treatment were used in the management of 64.3% (18/28) of patients. The median number of days of antibiotic treatment prior to surgical intervention in this subgroup was 2 days (range 1-37; IQR 2-5). The median number of surgical procedures following the diagnosis of P. acnes infection in this subgroup was 2 (range: 1-7; IQR 1-3), with an average of 19 (range 2-70; IQR 9-40) days of antibiotic treatment. Cefotaxime was the most commonly used antibiotic in this subgroup of patients (50%; 9/18). In this subgroup 4 patients died of causes unrelated to P. acnes infection; in 3 cases no outcome data were available (due to transfer to another hospital). Ten of the remaining 11 patients were reported to be cured from infection at follow-up; one patient experienced symptomatic improvement but had residual right-sided hemiparesis. The median duration of hospital stay was 12 days (range 3-119; IQR 8-39). 

The remaining 35.7% (10/28) of cases were treated by surgical intervention alone. The median number of procedures in this subgroup was 2 (range 1-6; IQR 1-3). One patient died of causes unrelated to P. acnes infection; in 2 cases no outcome data were available (due to transfer). The remaining 7 patients were reported to be cured from infection at follow-up. The median duration of hospital stay in this subgroup was 8 days (range 3-57; IQR 5-16). 

Almost all (93.8%; 15/16) of the neurosurgical cases with foreign material in situ had this material removed as part of the treatment of P. acnes infection. 

A comparison of the duration of hospital stay between the subgroup of patients treated with a combination of antibiotics and surgery and the subgroup that received surgical treatment alone revealed no statistically significant difference (p=0.1953). Equally, there was no significant difference in the rate of cure from infection between the two subgroups (p=1.0000).

Orthopaedic infections
The demographic characteristics of the 15 cases with orthopaedic infections are shown in Table 1. Twelve patients (80.0%) had bone infections; the most common infection site was the spine (n=5). The remaining three (20.0%) had septic arthritis. None of the pre-defined co-morbidities were identified in any of the cases in this group. 

Predisposing factors comprised prior orthopaedic surgery and/or trauma, present in 93.3% of cases (surgery only n=9; trauma followed by surgery n=5). No predisposing factors were identified in one case with septic arthritis of the talocrural joint. Foreign material was in situ at the site of infection in 80.0% (12/15) of cases; the most common types of foreign material were plates (n=6) and spinal rods (n=3). The median time interval between surgery or trauma and presentation with P. acnes infection was 5.0 weeks (range 2.0-78.0 weeks). 

The presenting symptoms and signs in this group are shown in Table 1. The most common features were discharge at the surgical/trauma site, and wound dehiscence, present in 91.7% and 81.8% of cases, respectively. Pyrexia was again uncommon, but in contrast to the neurosurgical cases, pain was present in the majority of cases (75.0%). 

The laboratory findings at presentation in this group are shown in Table 2. WBC and neutrophil counts were normal in 75.0% (9/12) and 75.0% (9/12) of cases, respectively. Among cases where CRP was analysed on admission, 75.0% (9/12) had results above the normal range. 

A combination of surgery and antibiotic treatment were used in the management of 93.3% (14/15) of patients; one patient received no antibiotic therapy, but underwent removal of an internal fixator. The median number of days of antibiotic treatment prior to surgical intervention in this group was 4 days (range 1-286; IQR 3-13). The median number of surgical procedures following the diagnosis of P. acnes infection in this group was 1 (range 1-3; IQR 1-3). Overall, 58.3% (7/12) of patients with foreign material in situ had this removed as part of their treatment (removal of infected wires, plates or screws (n=5); removal of spinal rods (n=1); complete revision of a total knee replacement (n=1)).

The average duration of antibiotic treatment in this group was 53 days (range 8-100; IQR 40-86). Flucloxacillin and amoxicillin were the most commonly used antibiotics in this group (n=5 and n=4, respectively). 

Cure from infection was reported in 92.9% (13/14) of cases where follow-up was recorded. The remaining patient, who had originally undergone internal fixation and arthrodesis following a tibial fracture, and subsequently required removal of the metalwork and two further surgical revisions, showed little improvement 4 months after the last revision.

Comparison of neurosurgical and orthopaedic infections
The statistical comparisons between the neurosurgical and orthopaedic cases are shown in Tables 1 and 2. Pain, discharge from the wound/operation site and wound dehiscence were significantly more common in the group with orthopaedic infections (Table 1). 

Despite the absence of statistically significant differences in the laboratory findings between the two groups, there was a tendency for patients with neurosurgical infections to have higher WBC and neutrophil counts at presentation (Table 2). 

There was no significant difference in the number of surgical procedures between the two groups, but the average duration of antibiotic therapy was significantly longer in the group with orthopaedic infections (median 53 days) compared to the group with neurosurgical infections (median 19 days; p=0.0025).

Infections involving other sterile sites
A total of 6 cases of P. acnes infection at another sterile site were identified. This comprised two cases of deep wound infections (one following mediastinoscopy, one following corrective surgery for pectus excavatum), and one case each of endocarditis with aortic root abscess (in a patient with an artificial aortic heart valve; P. acnes isolated from blood and aortic valve tissue), a cardiac pacemaker infection (P. acnes isolated from surrounding tissue and pacemaker leads), an infected carotid patch, and thoracic empyema (in a 71-year-old patient without significant co-morbidities or history of prior surgery). 

Antimicrobial susceptibility of invasive P. acnes isolates
Susceptibility data were available in 43 out of 49 cases. In all patients in whom P. acnes was grown from two or more specimens, the antimicrobial susceptibility pattern of all isolates was identical. Therefore only one isolate per patient was included in the analysis. 





This study shows that neurosurgical and orthopaedic infections account for the majority of invasive P. acnes infections in a non-selective patient population. Invasive P. acnes infections involving other sites or systems were uncommon, accounting for only 12.2% of the cases in this study. To our knowledge, only one previous study investigated the spectrum of invasive P. acnes infections in a non-selective patient population comprising both children and adults, without reporting detailed clinical manifestations or outcome in the majority of cases [9]. However, in accordance with our findings, CNS infections and osteoarticular infections accounted for a large proportion of cases in that report.    

Our data indicate that spontaneous invasive P. acnes infections are rare. All cases with neurosurgical P. acnes infection had either undergone neurosurgery or sustained a significant head injury. Similarly, all but one of the cases with orthopaedic P. acnes infection had undergone surgery or sustained significant trauma at the site of infection, or both. In only two cases (4.1%) of the entire study population were no predisposing factors identified (the cases with infection of the talocrural joint and thoracic empyema), suggesting that these infections had occurred spontaneously. This observation is in keeping with the marked predominance of reports describing invasive P. acnes infections following neurosurgical and orthopaedic surgery among the literature, and the paucity of publications reporting cases without apparent risk factors  ADDIN EN.CITE [11-22, 25-27].

In accordance with previous studies, we found that the majority of cases had foreign material in situ at the site of infection  ADDIN EN.CITE [9, 11, 13, 16, 27]. It appears likely that these materials were contaminated during surgery, resulting in colonisation, and subsequent progression to invasive infection. The association between invasive P. acnes infections and presence of foreign material likely results from the propensity of the organism to colonise surfaces and form biofilms, which has been demonstrated in several in vitro studies  ADDIN EN.CITE [5, 28, 29]. As for all biofilm-related infections, P. acnes in biofilm phenotype are more resistant to antimicrobial agents than planktonic (free-living) P. acnes, explaining why P. acnes infections with foreign material in situ often respond insufficiently to antimicrobial therapy alone  ADDIN EN.CITE [5, 28, 30]. This is highlighted by the fact that in 93.8% of the neurosurgical cases and in 58.3% of the orthopaedic cases in this study the foreign material was removed as part of the treatment of the infection. Surgery alone was curative in several of those cases, further supporting the role of biofilm formation in the pathogenesis of invasive P. acnes infections.

The interval between surgery and presentation was greater than one month in the majority of patients, reflecting the fact that P. acnes is an organism with comparatively slow growth and low virulence  ADDIN EN.CITE [10], which contrasts with other bacteria that are common causative agents of post-surgical infections, such as Staphylococcus aureus, where most patients develop symptoms within the first month [31]. The low virulence of P. acnes is further illustrated by the observation that only the minority of patients had systemic symptoms, or elevated WBC or neutrophil counts at the time of presentation, which again contrasts with other purulent infections.  

Our data show that P. acnes infections can cause significant morbidity. A substantial proportion of patients required multiple surgical interventions to treat the infection, and most patients required antibiotic therapy for several weeks. This was particularly evident in the group of patients with orthopaedic infections, where the average duration of antibiotic therapy was 53 days. However, despite the need for surgical intervention and prolonged antibiotic therapy, the overall outcome was favourable in the majority of cases. It remains uncertain why the average duration of antibiotic therapy in the group of orthopaedic cases was significantly longer than in the neurosurgical group. This could simply be due to differences in personal practice between the surgical teams, but could be related to the fact that the foreign material present at the site of infection was removed in almost all of the neurosurgical patients, while the foreign material was retained in situ in almost half of the orthopaedic cases. 

The antimicrobial susceptibility data suggest that the susceptibility pattern of P. acnes isolates from invasive infections does not differ significantly from those of P. acnes isolates cultured from skin and other body surfaces  ADDIN EN.CITE [32-35]. None of the isolates were resistant to β-lactam antibiotics, and only one isolate was resistant to clindamycin. 

Limitations
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Figure 1. Antimicrobial susceptibilities of invasive P. acnes isolates














Table 1. Demographics and presenting features of P. acnes infection in neurosurgical and orthopaedic cases 

	Neurosurgical cases(n=28)	Orthopaedic cases(n=15)	p-value
Age at presentation (years), median (IQR)	49.0(35-63)	37.0(23-53)	0.1047
Male gender, % (no.)	60.8 (17/28)	80.0 (12/15)	0.1948
Interval between surgery/trauma and presentation with infection (weeks), median (IQR) *	7.5(3.0-22.5)	5.0(3.1-12.8)	0.5471
Presenting features **			
    Pyrexia, % (no.)	11.5 (3/26)	7.7 (1/13)	1.0000
    Pain, % (no.)	6.3 (1/16)	75.0 (9/12)	0.0003
    Wound/site erythema, % (no.)	16.7 (1/6)	62.5 (5/8)	0.1375
    Wound/site swelling, % (no.)	66.7 (6/9)	71.4 (5/7)	1.0000
    Wound/site tenderness, % (no.)	50.0 (4/8)	57.1 (4/7)	1.0000
    Wound/site discharge, % (no.)	37.5 (3/8)	91.7 (11/12)	0.0181
    Wound/site dehiscence, % (no.)	16.7 (1/6)	81.8 (9/11)	0.0345
    Meningitic signs, % (no.)	19.0(4/21)	-	-
    Headache, % (no.)	33.3(7/21)	-	-
    Reduced level of consciousness, % (no.)	28.0(7/25)	-	-
    Focal neurological abnormalities, % (no.) ***	47.8(11/23)	-	-
    Seizures, % (no.)	23.8(5/21)	-	-
    Restriction of movement	-	80.0(4/5)	-
* Excludes one case with P. acnes infection of the talocrural joint that occurred without prior surgery or trauma.
** Number refers to number of cases in whom a feature was present of number of cases in whom this feature was recorded.
*** Comprising unilateral limb weakness (n=4), dysphagia (n=3), blurred vision (n=1), facial weakness (n=1), and dysphasia (n=1).






Table 2. Laboratory parameters at presentation, treatment and outcome of P. acnes infection in neurosurgical and orthopaedic cases 

	Neurosurgical cases(n=28)	Orthopaedic cases(n=15)	p-value
Laboratory parameters at presentation			
    WCC (x109/L), median (IQR)	9.2(7.6-10.3)	7.9(6.5-10.6)	0.3342
    Neutrophil count (x109/L), median (IQR)	6.95(4.8-8.2)	4.5(3.4-7.6)	0.1202
    CRP (mg/L), median (IQR)	8.3(2.0-59.9)	20.0(5.0-56.5)	0.7593
    ESR (mm/hr), median (IQR)	25(2-41)	9(4-33)	0.9184
Treatment			
    No. of surgical procedures, median (IQR)	2(1-3)	1(1-3)	0.4653
    Duration of antibiotic therapy (days),     median (IQR)	19(9-40)	53(40-86)	0.0025
Course & Outcome 			
    Duration of hospital stay (days), median (IQR)	9(7-23)	7(3-19)	0.1787
    Cure at follow-up, % (no.) *	94.4(17/18)**	92.9(13/14)	1.0000
* Number refers to number of cases who were reported as cured at follow-up of the total number of cases who had a follow-up visit.
** Excludes 5 cases who died of causes unrelated to P. acnes infection, and 5 in whom the outcome is unknown. 
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